Market Overview

15 Biggest Mid-Day Gainers For Monday

  • TG Therapeutics Inc (NASDAQ: TGTX) shares surged 88.8 percent to $10.10 after the company disclosed that Phase 3 GENUINE study met its primary endpoint.
  • Concert Pharmaceuticals Inc (NASDAQ: CNCE) shares climbed 79.5 percent to $17.32. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced plans to acquire CTP-656 from Concert Pharma for $160 million in cash and potential $90 million in milestones.
  • Dextera Surgical Inc (NASDAQ: DXTR) shares jumped 36.8 percent to $1.56 after the company disclosed that MicroCutter 5/80 surgical stapler enabled shorter hospital stays through less invasive lobectomy.
  • ChinaCache International Holdings Ltd (NASDAQ: CCIH) shares climbed 23 percent to $2.46 as the company agreed to sell data center assets for total consideration of RMB$221.2 million.
  • Skypeople Fruit Juice Inc (NASDAQ: SPU) shares rose 18 percent to $5.93 as the company disclosed that it has entered into one-year business agreement with China Aigo O2O Technology Inc.
  • Quest Resource Holding Corp (NASDAQ: QRHC) gained 14.7 percent to $2.51. Rodman & Renshaw initiated coverage on Quest Resource with a Buy rating.
  • Novan Inc (NASDAQ: NOVN) surged 14.1 percent to $7.29. Novan announced plans to continue SB204 development program.
  • NXT-ID Inc (NASDAQ: NXTD) shares rose 13.1 percent to $2.07.
  • Polar Power Inc (NASDAQ: POLA) shares gained 12.5 percent to $9.88 after the company reported 2016 financial results.
  • Ever-Glory International Group Inc (NASDAQ: EVK) shares surged 12 percent to $2.80.
  • Bellerophon Therapeutics Inc (NASDAQ: BLPH) shares gained 9 percent to $1.53.
  • Advaxis, Inc. (NASDAQ: ADXS) rose 7.4 percent to $9.90 after the company reported the FDA acceptance of IND for ADXS-NEO. The company announced plans to initiate Phase 1 trial in 2017.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 7.1 percent to $5.15 after gaining 6.18 percent on Friday.
  • Minerva Neurosciences Inc (NASDAQ: NERV) shares surged 5.4 percent to $8.75. Jefferies initiated coverage on Minerva Neurosciences with a Buy rating.
  • PTC Therapeutics, Inc. (NASDAQ: PTCT) shares gained 4 percent to $10.20. PTC Therapeutics reported FDA acknowledgment of NDA filing for Translarna.

Latest Ratings for TGTX

Mar 2019Initiates Coverage OnOverweight
Sep 2018DowngradesStrong BuyOutperform
Dec 2017ReinstatesBuy

View More Analyst Ratings for TGTX
View the Latest Analyst Ratings

Posted-In: Mid-Day GainersNews Intraday Update Analyst Ratings Movers


Related Articles (ADXS + AUPH)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

RBC Hints At Potential M&A For Kite Pharma

TD Ameritrade's Investor Movement Index (IMX) For February 2017